With more than one billion women expected to have entered menopause worldwide by 2025, Bonafide is highlighting the need to increase education on preparing, managing, and addressing solutions for menopause symptoms.
Health ingredients firm Acatris has developed a directly
compressible version of its SoyLife brand soy isoflavone
ingredient, designed to remove some of the hurdles for companies
looking to offer isoflavone capsules or tablets.
Soy is unlikely to damage fertility in women, report researchers,
who investigated the theory that its positive impact on breast
cancer risk may have other, unwanted effects.
Taking combined HRT can sharply increase the risk of developing a
blood clot for some women, according to new research, that adds to
the other risks associated with the therapy.
Women are going back onto hormone replacement therapy because it is
significantly more effective against menopausal symptoms than
herbal remedies, an organisation of American gynecologists said on
Friday.
The health effects of soy in post-menopausal women are to be
explored at the Keck School of Medicine of USC in a trial sponsored
by the National Institute of Health, to see whether soy is a viable
alternative to current hormone therapy.
A Swedish study established to assess the effect of hormone
replacement therapy (HRT) for women with a history of breast cancer
has been stopped early after preliminary results show 'unacceptably
high' risks of breast cancer...
A major study of the effects of hormone replacement therapy has
been halted after scientists discovered a major risk of ovarian
cancer - but there are plenty of natural alternatives to help women
deal with the menopause.